Clinical Trial Update: A Clinical Trial to Evaluate the Efficacy and Safety of Pitavastatin/Fenofibrate in Complex-dyslipidemia [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating pitavastatin/fenofibrate for complex-dyslipidemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Complex-dyslipidemia

Drugs mentioned

• Pitavastatin/Fenofibrate (pitavastatin/fenofibrate)

Snippet

Sponsor: Hanlim Pharm. Co., Ltd. | Conditions: Complex-dyslipidemia | Phase 3 | Status: COMPLETED